Eli Lilly
1,605 hedge funds and large institutions have $101B invested in Eli Lilly in 2019 Q1 according to their latest regulatory filings, with 159 funds opening new positions, 443 increasing their positions, 755 reducing their positions, and 102 closing their positions.
56% more first-time investments, than exits
New positions opened: 159 | Existing positions closed: 102
32% more call options, than puts
Call options by funds: $1.62B | Put options by funds: $1.23B
8% more capital invested
Capital invested by funds: $94.2B → $101B (+$7.13B)
3% more funds holding
Funds holding: 1,561 → 1,605 (+44)
2.47% less ownership
Funds ownership: 78.03% → 75.55% (-2.5%)
21% less funds holding in top 10
Funds holding in top 10: 62 → 49 (-13)
41% less repeat investments, than reductions
Existing positions increased: 443 | Existing positions reduced: 755
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$523M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$402M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$337M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$263M |
| 5 |
APG Asset Management
Amsterdam,
Netherlands
|
+$250M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.17B |
| 2 |
BlackRock
New York
|
-$958M |
| 3 |
Primecap Management
Pasadena,
California
|
-$896M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$620M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$597M |
LLY Hedge Fund Activity: Q1 2019 in Review
1,605 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q1 2019, worth a combined $101B — up 7.6% from $94.2B a quarter earlier.
Buyers outnumbered sellers: 159 funds opened new LLY positions and 102 closed out — a net gain of 57 holders — while 443 added to existing stakes and 755 trimmed.
The largest buyer was Capital International Investors, adding an estimated $523M. The largest seller was Wellington Management Group, cutting an estimated $1.17B.
- 1,605 institutional investors held Eli Lilly (LLY) as of Q1 2019, up from 1,561 in Q4 2018.
- Funds reported $101B of Eli Lilly stock for Q1 2019, up 7.6% quarter-over-quarter.
- 159 funds opened new Eli Lilly positions in Q1 2019 and 102 closed out, a net change of +57 holders.
- The largest Eli Lilly buyer in Q1 2019 was Capital International Investors, an estimated $523M added.
- The largest Eli Lilly seller in Q1 2019 was Wellington Management Group, an estimated $1.17B sold.
Based on aggregated 13F filings for Q1 2019.